| Literature DB >> 31426430 |
Elke Humer1, Geert Bruggeman2, Qendrim Zebeli3.
Abstract
After parturition, cows undergo negative energy balance leading to fat mobilization, predisposing them to fatty liver syndrome and ketosis with major consequences for health and reproduction. Supplementation of rumen-protected choline (RPC) has attracted major research efforts during the last decade, assuming that choline improves liver function by increasing very low-density lipoprotein exportation from the liver, thereby improving metabolic profiles, milk production, and reproduction. However, the effects of RPC on production, health, and reproduction have been inconsistent. Therefore, the aim of this meta-analysis was to evaluate the effects of RPC supplementation, starting from d 20 (± 12.2) ante partum to d 53 (± 31.0) postpartum, on feed intake, milk production performance and metabolic profiles of dairy cows early postpartum. Data analyses from 27 published studies showed an increase in postpartal dry matter intake (from on average 19.1 to 19.9 kg/d; p < 0.01) and milk yield (from on average 31.8 to 32.9 kg/d; p = 0.03) in cows receiving RPC. Milk fat yield and milk protein yield were also increased (p ≤ 0.05), without changing milk protein and fat contents. However, no interactive effects between cow's milk yield level and RPC-supplementation as well as no dose-dependent effects of RPC supplementation were observed. Supplementing the diet with RPC showed no effects on blood metabolites (non-esterified fatty acids, beta-hydroxybutyrate, glucose, and cholesterol), independent of the milk yield level of the cows. An effect on liver triacylglycerol contents, incidence of ketosis, and mastitis could not be confirmed across all studies included in this meta-analysis. Also, the positive effects of RPC supplementation on reproductive performance were not consistent findings. In conclusion, supplementing RPC in lactating dairy cows showed positive effects on dry matter intake which likely caused the improved milk yield. However, RPC supplementation did not improve the metabolic health status of the cows. As several factors might be related to the responses to RPC, further research is needed to explore the precise mechanisms of RPC action in lactating cows, especially with regards to feed intake improvement and its related metabolic health-promoting potential in early lactating dairy cows.Entities:
Keywords: cow fertility; cow health; meta-analysis; milk production; rumen-protected choline
Year: 2019 PMID: 31426430 PMCID: PMC6720594 DOI: 10.3390/ani9080566
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
List of studies used to evaluate the effect of dietary rumen-protected choline (RPC) supplementation on dry matter intake (DMI), milk yield (MY), milk fat content (MFC), milk protein content (MPC), non-esterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA), glucose and cholesterol in lactating dairy cows.
| Reference | Cows/Treatment | Dose, g/d of Choline Chloride | Duration | Variables |
|---|---|---|---|---|
| Hartwell et al. [ | 16 | 0 | 28 d a.p. to | DMI, MY, MFC, MPC |
| Piepenbrink and Overton [ | 12 | 0 | 21 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA |
| Pinotti et al. [ | 13 | 0 | 14 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA, Glucose, Cholesterol |
| Zahra et al. [ | 45 | 0 | 21 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA, Glucose, Cholesterol |
| Janovick Guretzky et al. [ | 21 | 0 | 21 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA, Glucose, Cholesterol |
| Xu et al. [ | 7 | 0 | 7 d a.p. to | DMI, MY, MFC, MPC, NEFA, Glucose, Cholesterol |
| Xu et al. [ | 9 | 0 | 7 d a.p. to | DMI, MY, MFC, MPC, NEFA, Glucose, Cholesterol |
| Cooke et al. [ | 12 | 0 | 45–60 d a.p. to | NEFA, BHBA, Glucose |
| Lima et al. [ | 179 | 0 | 25 d a.p. to | DMI, MY |
| Davidson et al. [ | 20 | 0 | 21 DIM to | DMI, MY, MFC, MPC, NEFA, BHBA, Cholesterol |
| Elek et al. [ | 16 | 0 | 28 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA, Glucose, Cholesterol |
| Chung et al. [ | 6 2 | 0 | Start: 41 DIM, | DMI, MY, NEFA, BHBA, Glucose |
| Ardalan et al. [ | 10 | 0 | 28 d a.p. to | DMI, MY, MFC, MPC |
| Mohsen et al. [ | 12 3 | 0 | Start: 56 DIM, | DMI, MY, MFC, MPC, Glucose, Cholesterol |
| Suksombat et al. [ | 8 | 0 | 32 DIM to | DMI, MY, MFC, MPC, NEFA, BHBA, Cholesterol |
| Zom et al. [ | 19 | 0 | 21 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA, Glucose |
| Garg et al. [ | 8 | 0 | 14–21 DIM to | DMI, MY, MFC, MPC, NEFA, Glucose, Cholesterol |
| Soltan et al. [ | 15 | 0 | 0 to | DMI, MY, MFC, MPC, NEFA, Glucose, Cholesterol |
| Rahmani et al. [ | 8 | 0 | 35 DIM to | DMI, MY, MFC, MPC |
| Leiva et al. [ | 11 | 0 | 21 d a.p. to | MY, MFC, MPC, NEFA, BHBA, Glucose |
| Pawar et al. [ | 5 | 0 | 28 d experimental period | MY, MFC, MPC |
| Pineda and Cardoso [ | 25 | 0 | Start: >80 DIM, 63 d experimental period | DMI, MY, MFC, MPC, NEFA |
| De Veth et al. [ | 5 2 | 0 | Start: 206 DIM, 5 d/period | DMI, MY, MFC, MPC |
| Zhou et al. [ | 20 | 0 | 21 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA, Glucose |
| Pirestani and Aghakhani [ | 30 | 0 | 7 d a.p. to | MY, MFC, MPC, BHBA |
| Cetin et al. [ | 8 | 0 | 21 d a.p. to | DMI, MY, MFC, MPC |
| Zenobi et al. [ | 47 | 0 | 17 d a.p. to | DMI, MY, MFC, MPC, NEFA, BHBA, Glucose |
Abbreviations: a.p., ante partum; DIM, days in milk; p.p., post partum. 1 Two independent experiments. 2 Latin square design. 3 Switch-back design.
Commercial rumen-protected choline products used in the different studies.
| Product | Manufacturer | Study | Choline Chloride, % (wt/wt) | Rumen Stability, % |
|---|---|---|---|---|
| CapShure choline | Balchem Corp., Slate Hill, NY, USA | Hartwell et al. [ | 25 | 85 1 |
| Reashure | Blachem Corp., New Hampton, NY, USA | Piepenbrink and Overton [ | 25 | 85 1 |
| - | - | Xu et al. [ | 37.5 | 70 |
| Overcholine 45% Coated | Ascor Chimici, Forli, Italy | Pinotti et al. [ | 45 | - |
| Norcol-25 | Nordos Italy, Bussolengo, Italy | Elek et al. [ | 25 | 20.4 3 |
| Pro-Choilne 50 | Probiotech Inc., Saint-Hyacinthe, QC, Canada | Chung et al. [ | 50 | 50 4 |
| COL24 | Soda Feed Ingredients, Monaco, France | Ardalan et al. [ | 24 | - |
| CholiPearl | Kemin Agrifoods, South America | Leiva et al. [ | 18.8 | - |
| - | Robt Morgan Inc., Paris, IL, USA | Davidsson et al. [ | 23 | 28.7 |
| - | Qingdao Worldwide International Trade | Mohsen et al. [ | - | - |
| - | - | Garg et al. [ | - | 71.3 |
| Kemin Industries South Asia Pvt. Ltd., Tamilnadu, | Pawar et al. [ | 25.4 | 69.2 5 | |
| Soda Food Supplement | Sana Dam Pars Company, Shamsabad, Iran | Pirestani and Aghakhani [ | 25 | - |
1 In vitro analysis [38]; 2 After up to 72 h in situ incubation in rumen-cannulated steers [39]; 3 After 8 h in situ incubation in rumen-cannulated adult ewes [40]; 4 After 48 h in situ incubation in rumen-cannulated cows [41]; 5 After 24 h in situ incubation in rumen-cannulated bulls [30].
Statistics for dependent variables.
| Item | Studies, | Values, | Mean | SE | Min. | Max. | Median |
|---|---|---|---|---|---|---|---|
| DMI, kg/d | 23 | 64 | 19.5 | 0.49 | 12.2 | 28.5 | 20.0 |
| Milk yield, kg/d | 26 | 71 | 32.0 | 1.14 | 10.0 | 48.9 | 32.5 |
| Fat content, % | 24 | 66 | 3.94 | 0.09 | 2.64 | 6.50 | 3.89 |
| Fat yield, kg/d | 24 | 66 | 1.20 | 0.05 | 0.36 | 1.82 | 1.27 |
| Protein content, % | 24 | 66 | 3.14 | 0.04 | 2.44 | 4.53 | 3.11 |
| Protein yield, kg/d | 24 | 66 | 0.96 | 0.03 | 0.36 | 1.38 | 1.01 |
| NEFA, mmol/L | 19 | 46 | 0.57 | 0.03 | 0.17 | 1.19 | 0.56 |
| BHBA, mmol/L | 14 | 36 | 0.78 | 0.08 | 0.15 | 1.86 | 0.57 |
| Glucose, mg/dL | 15 | 36 | 60.0 | 1.42 | 44.6 | 80.6 | 58.4 |
| Cholesterol, mg/dL | 11 | 28 | 143 | 6.80 | 78.3 | 210 | 148 |
Abbreviations: DMI, dry matter intake; NEFA, non-esterified fatty acids; BHBA, beta-hydroxybutyrate; SE, standard error.
Dry matter intake (DMI), milk yield and constituents and blood metabolites of either control cows (CON) or cows supplemented with rumen-protected choline (RPC).
| Item | CON | RPC |
| SEM | |
|---|---|---|---|---|---|
| DMI, kg/d | 19.06 | 19.85 | 64 | 0.829 | <0.001 |
| Milk yield, kg/d | 31.80 | 32.85 | 71 | 1.872 | 0.032 |
| Fat content, % | 3.843 | 3.873 | 66 | 0.149 | 0.544 |
| Fat yield, kg/d | 1.167 | 1.215 | 66 | 0.0754 | 0.012 |
| Protein content, % | 3.162 | 3.166 | 66 | 0.0735 | 0.784 |
| Protein yield, kg/d | 0.964 | 0.995 | 66 | 0.0569 | 0.054 |
| NEFA, mmol/L | 0.571 | 0.563 | 46 | 0.0499 | 0.692 |
| BHBA, mmol/L | 0.760 | 0.769 | 36 | 0.1149 | 0.744 |
| Glucose, mg/dL | 59.95 | 60.50 | 36 | 2.386 | 0.461 |
| Cholesterol, mg/dL | 145.5 | 146.3 | 28 | 11.47 | 0.862 |
Abbreviations: NEFA, non-esterified fatty acids; BHBA, beta-hydroxybutyrate.
Dry matter intake (DMI), milk yield and constituents and blood metabolites as affected by supplementation dose of choline chloride deriving from rumen-protected choline (RPC) in lactating dairy cows.
| Response Variable 1 ( | Parameter Estimates | Model Statistics | ||||||
|---|---|---|---|---|---|---|---|---|
| nTreat 2 | Intercept | SEIntercept | Slope | SESlope | RMSE |
| ||
| DMI, kg/d | 64 | 19.39 | 0.6613 | 0.0141 | 0.0447 | 3.9385 | 0.0016 | 0.754 |
| Milk yield, kg/d | 71 | 32.94 | 1.5641 | −0.0930 | 0.1016 | 9.6481 | 0.0120 | 0.363 |
| Fat content, % | 66 | 3.864 | 0.1187 | 0.0070 | 0.0077 | 0.7092 | 0.0129 | 0.364 |
| Protein content, % | 66 | 3.104 | 0.0541 | 0.0030 | 0.0035 | 0.3232 | 0.0111 | 0.401 |
| NEFA, mmol/L | 46 | 0.5490 | 0.0394 | 0.0017 | 0.0026 | 0.2023 | 0.0094 | 0.521 |
| BHBA, mmol/L | 36 | 0.7751 | 0.1004 | 0.0006 | 0.0066 | 0.4570 | 0.0002 | 0.932 |
| Glucose, mg/dL | 36 | 60.09 | 1.9054 | −0.0116 | 0.1240 | 8.6668 | 0.0003 | 0.926 |
| Cholesterol, mg/dL | 28 | 143.93 | 8.8892 | −0.1251 | 0.5182 | 36.6159 | 0.0022 | 0.811 |
1 Abbreviations: NEFA, non-esterified fatty acids, BHBA, beta-hydroxybutyrate; 2 nTreat = number of treatment means included.
Figure 1The relationship between the level of dietary supplementation with choline chloride in the form of rumen-protected choline (RPC) ranging from 6 to 50 g per cow per day and the relative change in dry matter intake compared to unsupplemented control cows reported by the studies summarized in Table 1.
Figure 2The relationship between the level of dietary supplementation with choline chloride in the form of rumen-protected choline (RPC) ranging from 6 to 50 g per cow per day and the relative change in milk yield compared to unsupplemented control cows reported by the studies summarized in Table 1.
Effect of rumen-protected choline (RPC) supplementation of dairy cows on postpartum disorders.
| Reference | Cows/Treatment | Dose, g/d of Choline Chloride | Duration | Observed Effects of Feeding RPC |
|---|---|---|---|---|
| Piepenbrink and Overton [ | 12 | 0 | 21 d a.p. to 63 DIM | overall no retained placenta, numerical higher DA and ketosis in cows fed 15 g RPC; |
| Janovick Guretzky et al. [ | 21 | 0 | 21 d a.p. to 21 DIM | no effect on the incidence of milk fewer, metritis, DA, ketonuria, mastitis, foot/leg problems, more twinings, tendency toward more retained placenta |
| Lima et al. [ | 183 | 0 | 25 d a.p. to 80 DIM | lower incidence of clinical ketosis, mastitis, mastitis cases per cow, morbidity, no effect on retained fetal membranes, fever, metritis, DA, mortality |
| Lima et al. [ | 282 2 | 0 | 21 d a.p. to parturition | no effect on clinical ketosis, mastitis, lower number of mastitis cases per cow, no effect on DA, trend toward higher morbidity due to increased incidence of metritis and fever, higher incidence of retained fetal membranes |
| Davidson et al. [ | 20 | 0 | 21 DIM to 91 DIM | lower ketosis incidence in multiparous cows |
| Ardalan et al. [ | 10 | 0 | 28 d a.p. to 98 DIM | Numerical lower incidence of mastitis, retained placenta, uterine problems, and dystocia; overall no ketosis, DA, milk fever and foot/leg problems |
| Furken and Hoedemaker [ | 149 | 0 | 21 d a.p. to 21 DIM | Lower incidence of subclinical endometritis, higher sickness rates after day 100 postpartum |
| Zhou et al. [ | 20 | 0 | 21 d a.p. to 30 DIM | Numerical lower incidence of ketosis; no effect on displaced abomasum, retained placenta and mastitis |
| Pirestani and Aghakhani [ | 30 | 0 | 7 d a.p. to 28 DIM | lower somatic cell count; overall no ketosis, mastitis, lameness, dystocia |
| Zenobi et al. [ | 47 | 0 | 17 d a.p. to 21 DIM | no effect on fever, uterine diseases, hyperketonemia, ketosis, mastitis, digestive upsets, morbidity |
Abbreviations: a.p., ante partum; DA, displaced abomasum; DIM, days in milk; p.p., postpartum. 1 Two independent experiments. 2 Only primiparous cows.
Effect of rumen-protected choline (RPC) supplementation of dairy cows on reproductive performance.
| Reference | Cows/Treatment | Dose, g/d of Choline Chloride | Duration | Observed Effects of RPC Supplementation |
|---|---|---|---|---|
| Ardalan et al. [ | 10 | 0 | 49 d a.p. to 98 DIM | no effect on days to first estrus, open days and services per conception, numerical higher number of pregnant cows (60% vs. 30%) |
| Furken and Hoedemaker, [ | 149 | 0 | 21 d a.p. to 21 DIM | higher number of cyclic cows in week 5 postpartum (50% vs. 41%) |
| Lima et al. [ | 183 | 0 | 25 d a.p. to 80 DIM | no effect on reproduction (conception rate, percentage of cows cycling, pregnancy loss) but interactive effects between RPC and parity: primiparous cows receiving RPC: less likely to be cycling at 61 DIM (64% vs. 71%), multiparous cows receiving RPC: opposite effect (93% RPC-cows vs. 86% CON-cows cycling) |
| 282 2 | 0 | 21 d a.p. to parturition | no effect on reproduction (conception rate, pregnancy loss) | |
| Pirestani and Aghakhani [ | 30 | 0 | 7 d a.p. to 28 DIM | lower service/conception rate (1.8 vs. 2.5), longer time of calving to first service (67 d vs. 61 d) and calving to first visible oestrous (62 d vs. 54 d) |
Abbreviations: a.p., ante partum; DIM, days in milk; p.p., postpartum. 1 Two independent experiments. 2 Only primiparous cows.